Table 6. Other CEC characteristics by diagnostic grouping.
| Large nuclei | Irregular nuclear boarders | Anisonucleosis | High N/C ratio | Nuclear hyperchromasia | |
|---|---|---|---|---|---|
| Malignant-Present n (%) | 42 (46.7%) | 52 (57.8%) | 41 (45.6%) | 23 (28.4%) | 32 (35.6%) |
| Malignant-Absent n (%) | 48 (53.3%) | 38 (42.2%) | 49 (54.4%) | 58 (71.6%) | 58 (64.4%) |
| Benign-Present n (%) | 15 (60.0%) | 18 (72.0%) | 13 (52.0%) | 6 (25.0%) | 11 (44.0%) |
| Benign-Absent n (%) | 10 (40.0%) | 7 (28.0%) | 12 (48.0%) | 18 (75.0%) | 14 (56.0%) |
| p= | 0.27 | 0.25 | 0.17 | 0.80 | 0.49 |
| Neoplastic-Present n (%) | 52 (49.1%) | 63 (59.4%) | 52 (49.1%) | 28 (28.9%) | 39 (36.8%) |
| Neoplastic-Absent n (%) | 54 (50.9%) | 43 (40.6%) | 54 (50.9%) | 69 (71.1%) | 67 (63.2%) |
| Non-neoplastic-Present n (%) | 5 (55.6%) | 7 (77.8%) | 2 (22.2%) | 1 (12.5%) | 4 (44.4%) |
| Non-neoplastic-Absent n (%) | 4 (44.4%) | 2 (22.2%) | 7 (77.8%) | 7 (87.5%) | 5 (55.6%) |
| p= | 0.74 | 0.32 | 0.72 | 0.44 | 0.73 |
| PDAC-Present n (%) | 34 (47.2%) | 42 (58.3%) | 33 (45.8%) | 20 (30.8%) | 26 (36.1%) |
| PDAC-Absent n (%) | 38 (52.8%) | 30 (41.7%) | 39 (54.2%) | 45 (69.2%) | 46 (63.9%) |
| NET-Present n (%) | 3 (37.5%) | 3 (37.5%) | 3 (37.5%) | 0 (0%) | 2 (25.0%) |
| NET-Absent n (%) | 5 (62.5%) | 5 (62.5%) | 5 (62.5%) | 6 (100.0%) | 6 (75.0%) |
| p= | 0.72 | 0.46 | 0.72 | 0.17 | 0.71 |
CEC: Circulating epithelioid cells. PDAC: Pancreatic ductal adenocarcinoma. NET: Neuroendocrine tumor.